Xtant Medical to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
Xtant Medical Holdings (NYSE American: XTNT), a global medical technology company specializing in surgical solutions for spinal, orthopedic, and woundcare disorders, has announced its participation in the upcoming H.C. Wainwright 27th Annual Global Investment Conference.
CEO Sean Browne and CFO Scott Neils will represent the company at the conference, which takes place September 8-10, 2025, in New York and virtually. The company's presentation will be available on-demand starting September 5 at 7:00 A.M. ET. Management will also conduct virtual one-on-one meetings with investors on September 8th.
Xtant Medical Holdings (NYSE American: XTNT), azienda globale di tecnologia medicale specializzata in soluzioni chirurgiche per problemi spinali, ortopedici e di cura delle ferite, ha annunciato la sua partecipazione al 27° H.C. Wainwright Annual Global Investment Conference.
Il CEO Sean Browne e il CFO Scott Neils rappresenteranno la società alla conferenza, che si terrà dal 8 al 10 settembre 2025 a New York e in modalità virtuale. La presentazione sarà disponibile on-demand a partire dal 5 settembre alle 7:00 ET. La direzione effettuerà inoltre incontri virtuali one-to-one con gli investitori l'8 settembre.
Xtant Medical Holdings (NYSE American: XTNT), una compañía global de tecnología médica especializada en soluciones quirúrgicas para trastornos espinales, ortopédicos y de cuidado de heridas, ha anunciado su participación en la 27.ª Conferencia Anual Global de Inversión H.C. Wainwright.
El director ejecutivo Sean Browne y el director financiero Scott Neils representarán a la empresa en la conferencia, que se celebrará del 8 al 10 de septiembre de 2025 en Nueva York y de forma virtual. La presentación de la compañía estará disponible bajo demanda a partir del 5 de septiembre a las 7:00 a.m. ET. La dirección también llevará a cabo reuniones virtuales individuales con inversores el 8 de septiembre.
Xtant Medical Holdings (NYSE American: XTNT)는 척추, 정형외과 및 상처 치료 질환을 위한 외과 솔루션을 전문으로 하는 글로벌 의료기술 기업으로, H.C. Wainwright 제27회 연례 글로벌 투자 콘퍼런스에 참가한다고 발표했습니다.
CEO 숀 브라운(Sean Browne)과 CFO 스콧 닐스(Scott Neils)가 회사를 대표해 참석하며, 콘퍼런스는 2025년 9월 8일~10일 뉴욕과 온라인에서 진행됩니다. 회사 발표는 9월 5일 오전 7:00(동부시간)부터 온디맨드로 이용할 수 있습니다. 경영진은 또한 9월 8일 투자자들과의 가상 일대일 미팅을 진행할 예정입니다.
Xtant Medical Holdings (NYSE American: XTNT), une entreprise mondiale de technologie médicale spécialisée dans les solutions chirurgicales pour les pathologies de la colonne vertébrale, l'orthopédie et les soins des plaies, a annoncé sa participation à la 27e conférence annuelle mondiale d'investissement H.C. Wainwright.
Le PDG Sean Browne et le directeur financier Scott Neils représenteront la société lors de la conférence, qui se tiendra du 8 au 10 septembre 2025 à New York et en virtuel. La présentation de la société sera disponible à la demande à partir du 5 septembre à 7h00 (ET). La direction organisera également des réunions virtuelles individuelles avec des investisseurs le 8 septembre.
Xtant Medical Holdings (NYSE American: XTNT), ein globales Medizintechnikunternehmen, das sich auf chirurgische Lösungen für Wirbelsäulen-, orthopädische und Wundversorgungsstörungen spezialisiert hat, hat seine Teilnahme an der 27. H.C. Wainwright Annual Global Investment Conference angekündigt.
CEO Sean Browne und CFO Scott Neils werden das Unternehmen auf der Konferenz vertreten, die vom 8. bis 10. September 2025 in New York und virtuell stattfindet. Die Präsentation des Unternehmens ist on-demand ab dem 5. September um 7:00 Uhr ET verfügbar. Das Management wird außerdem am 8. September virtuelle Einzelgespräche mit Investoren führen.
- None.
- None.
A company presentation will be available on demand here as of Friday, September 5 at 7:00 A.M. (ET). In addition, Xtant's management team will be available for virtual one-on-one meetings on September 8th. Interested investors should contact their representative at H.C. Wainwright. A replay of the presentation will be posted to the Presentation & Events page of Xtant's Investors website for 90 days.
About Xtant Medical Holdings, Inc.
Xtant Medical's mission of honoring the gift of donation so that our patients can live as full and complete a life as possible, is the driving force behind our company. Xtant Medical Holdings, Inc. (www.xtantmedical.com) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics serving the chronic and surgical wound care and sports medicine markets, as well as spinal implant systems. Xtant people are dedicated and talented, operating with the highest integrity to serve our customers.
The symbols ™ and ® denote trademarks and registered trademarks of Xtant Medical Holdings, Inc. or its affiliates, registered as indicated in the
View original content to download multimedia:https://www.prnewswire.com/news-releases/xtant-medical-to-participate-in-the-hc-wainwright-27th-annual-global-investment-conference-302546574.html
SOURCE Xtant Medical Holdings, Inc.
FAQ
When is Xtant Medical (XTNT) presenting at the H.C. Wainwright Conference 2025?
Who will represent Xtant Medical at the H.C. Wainwright Conference?
How can investors access Xtant Medical's H.C. Wainwright Conference presentation?
How can investors schedule meetings with Xtant Medical management?
